| Quarter | Score |
|---|---|
| 2020-Q2 | 47.9 |
| 2022-Q1 | 50.6 |
| 2022-Q3 | 66.0 |
| 2022-Q4 | 49.6 |
| 2023-Q1 | 49.4 |
| 2023-Q2 | 63.7 |
| 2023-Q3 | 48.0 |
| 2023-Q4 | 36.4 |
| 2024-Q1 | 60.2 |
| 2024-Q2 | 72.0 |
| 2024-Q3 | 57.5 |
| 2024-Q4 | 57.5 |
| 2025-Q1 | 58.6 |
| 2025-Q2 | 61.8 |
| 2025-Q3 | 61.5 |
| 2025-Q4 | 61.7 |
| 2026-Q1 | 61.8 |
| 2026-Q2 | 77.4 |
High consensus with active accumulation at an attractive valuation
Trading 10.7% below funds' estimated purchase price
2 of 18 tracked funds hold PVH. Avg conviction: 0.5%. Net adding. First tracked at $87.54 (current -10.7% vs tracked).
Greenlight Capital has 1.0% in this stock
Benchmark comparison unavailable
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 17 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Greenlight Capital | 1.0% | New Buy |
| Citadel Advisors | 0.0% | Add |